l carnitine tmao γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO: Why It Increases &
Description
LinseisenJHoffmannJRiedlJet al
The study protocol was registered with Clinical Research Information Service (KCT0007386)
Metabolic reprogramming driven by oncogenes allows cancer cells to maintain deregulated cell proliferation, withstand metabolic challenges that are associated with diminished oxygen and nutrients, maintain a dedifferentiated state through alterations in global patterns of gene expression, and corrupt the surrounding microenvironment to actively facilitate tumor growth and dissemination 1618
J.ShakouriS
